AKT1 and neoplasm: In particular, miR-338 mainly functions as a tumor suppressor in different cancers, in which its expression is reduced leading to an upregulation of Wnt-β-catenin, MAPK, and PI3K/Akt signaling pathways (Lu et al., 2018).